0 CHECKOUT

PRODUCT FILTERS

REGION

23
4
3
3
3

COUNTRY

3
1
1
1
1

CATEGORIES

  • 16
  • 9
  • 7
  • 7
  • 6
  • 5
  • 4
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

16
24
34
62

PUBLISHED

1
2
11
62

PRODUCT TYPE

54
4
2
2

Search for: "Vertex Group Limited"

Ukraine Tourism Report Q2 2015

BMI View: Following a disastrous 2014, Ukraine is set to experience further declines in inbound tourism in 2015, albeit to a much lesser extent. Recovery over the next few years is expected to be slow,...

Published:  April 2015
Price: 

Tuberculosis - Pipeline Review, H2 2015

Tuberculosis - Pipeline Review, H2 2015 Summary The report ‘Tuberculosis - Pipeline Review, H2 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

South China Land Limited

A textual analysis of the financial results for South China Land Limited compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio...

Published:  November 2014
Price: 

Global Influenza Market - Vaccines and Therapeutics

The influenza virus has been implicated in infecting millions of individuals on an annual basis, with vaccination programs against seasonal influenza infections necessitating the manufacture of hundreds...

Published:  March 2016
Price:  From

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Cystic Fibrosis Therapeutics - Opportunity Analysis and Forecasts to 2017 Summary Cystic Fibrosis (CF) is an autosomal recessive disease characterized by the secretion of thick,...

Published:  April 2013
Price:  From

Tuberculosis - Pipeline Review, H1 2016

Tuberculosis - Pipeline Review, H1 2016 Summary ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape. The report provides comprehensive information...

Published:  May 2016
Price:  From

Hepatitis C - Pipeline Review, H1 2016

Hepatitis C - Pipeline Review, H1 2016 Summary ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape. The report provides comprehensive information...

Published:  April 2016
Price:  From

Hepatitis C - Pipeline Review, H2 2015

Hepatitis C - Pipeline Review, H2 2015 Summary The report ‘Hepatitis C - Pipeline Review, H2 2015’, provides an overview of the Hepatitis C’s therapeutic pipeline. This report provides comprehensive...

Published:  December 2015
Price:  From

Tuberculosis - Pipeline Review, H1 2015

Tuberculosis - Pipeline Review, H1 2015 Summary the, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline. This report provides comprehensive...

Published:  June 2015
Price:  From

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2015

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2015 Summary The report ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2015’, provides an overview of the Chronic...

Published:  December 2015
Price:  From

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016

Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016 Summary ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive...

Published:  April 2016
Price:  From

Ion Channel Modulators - Global Strategic Business Report

This report analyzes the worldwide markets for Ion Channel Modulators in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America,...

Published:  April 2015
Price:  From

Rare Diseases: The Pharmaceutical Landscape and Opportunity Areas

The service oriented and dynamic nature of the healthcare industry has led to the discovery of a plethora of treatment options for a wide range of ailments.However, there are certain diseases, termed...

Published:  March 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H1 2015

Multiple Sclerosis - Pipeline Review, H1 2015 Summary the, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report provides...

Published:  June 2015
Price:  From

Rheumatoid Arthritis - Pipeline Review, H1 2015

Rheumatoid Arthritis - Pipeline Review, H1 2015 Summary the, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline. This report...

Published:  June 2015
Price:  From

Multiple Sclerosis - Pipeline Review, H2 2015

Multiple Sclerosis - Pipeline Review, H2 2015 Summary The report ‘Multiple Sclerosis - Pipeline Review, H2 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline. This report...

Published:  December 2015
Price:  From

Hepatocellular Cancer Global Clinical Trials Review, Q4, 2010

Hepatocellular Cancer Global Clinical Trials Review, Q4, 2010 Summary Our clinical trial report, “Hepatocellualar Cancer Global Clinical Trials Review, Q4, 2010" provides data on the Hepatocellualar...

Published:  December 2010
Price:  From

Hepatitis C Virus and Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for Hepatitis C Virus And Therapeutics in US$ Millions Annual forecasts are provided for each region for the period of 2006 through 2015 The report profiles...

Published:  April 2009
Price:  From

Global Biopharma Outlook 2011

Global Pharmaceutical and Biotechnology Outlook 2011 is an extensive, yet conclusive research work that encompasses a comprehensive, historical and forward looking analysis of 80 small and large cap...

Published:  January 2011
Price:  From

Breast Cancer - Pipeline Review, H1 2015

Breast Cancer - Pipeline Review, H1 2015 Summary This, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline. This report provides comprehensive...

Published:  January 2015
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group